| Reference / SKU | DI 01-285-01 |
| Pattern | Macintosh |
| Working length | 148 mm (14.8 cm) |
| Material | AISI 303 / AISI 304 stainless steel (AISI 316 on fiber-optic variants) |
| Sterilization | Steam autoclave to 134 °C · EtO compatible |
| Quality system | ISO 13485:2016 · CE-marked under EU MDR 2017/745 · FDA establishment-registered |
Blechman 148mm Macintosh American Profile Conventional Blade (Ref DI 01-285-01), supplied from Fizza Surgical’s instrument range under ISO 13485:2016 quality management.
The Macintosh laryngoscope blade — designed by Scottish anaesthetist Robert Reynolds Macintosh in 1943 at Oxford — is the most widely used laryngoscope blade worldwide. The curved profile fits the tongue’s anatomy: the blade tip sits in the vallecula (the space between tongue base and epiglottis), and lifting the handle indirectly raises the epiglottis to expose the glottis. This indirect technique reduces the risk of damaging the epiglottis compared with the older Miller (straight) blade approach. Macintosh blades are manufactured in sizes 0 (neonatal) through 4 (large adult); sizes 3 and 4 cover most adult intubations. Modern fiber-optic Macintoshes have largely replaced bulb variants in operating theatres.
- Blechman 148mm Fiber Optic Macintosh American Profile Blade (DI 01-290-01)
- Mega Macintosh 150mm Fiber Optic?Laryngoscope Blade (DI 01-85-05)
- Fiber Optic Macintosh Blade 13cm (DI 01-150-01-01)
Every instrument is forged, machined, and finished at the Sialkot facility from German-origin stainless billet — austenitic 304 / 316 grades for non-cutting, mucosal-contact, and hollow-ware lines where corrosion resistance is the priority, martensitic 420 / 440 grades for cutting and edge-retention patterns where heat-treatable hardness matters, and 17-4 PH precipitation-hardened stainless for high-load orthopedic and implant-handling applications. Polishing, passivation, and final inspection are performed in-house under documented quality procedures aligned with ISO 13485:2016.





Reviews
There are no reviews yet.